NCT02005133终止不适用
A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 188
- 试验地点
- 1
- 主要终点
- Frequency of aflibercept administration
研究概览
简要总结
To assess the use of aflibercept over a 2 year period in VEGF inhibitor naive and prior treated wet AMD patients managed in 'real wold' clinic settings.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age greater or equal to 50 years Active choroidal neovascularisation secondary to AMD in one or both eyes which in the opinion of the investigator will benefit from treatment with aflibercept Subject willing and able to provide informed consent
排除标准
- •Patients must not have had any prior use of either bevacizumab or aflibercept
- •Other protocol-defined inclusion/exclusion criteria may apply
结局指标
主要结局
Frequency of aflibercept administration
时间窗: Up to 1 year
To assess the frequency of clinic visits over a 1 year period in VEGF inhibitor naive wet AMD patients managed in 'real world' clinic settings.
次要结局
- Change in central retinal thickness from baseline(Up to 2 years)
- Frequency of clinic visits(Up to 1 year)
- Changes in visual acuity from baseline(Up to 2 years)
- Aflibercept Administration(Up to 2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)Macular EdemaNCT02818998Bayer463
已完成
3 期
A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin ChemotherapyColorectal Cancer MetastaticNCT01661270Sanofi332
已完成
3 期
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Macular DegenerationNCT02540954Bayer336
已完成
2 期
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaPulmonary DiseasesNeoplasms, LungNCT00284141Sanofi98
已完成
4 期
Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular DegenerationWet Macular DegenerationNCT02305238Bayer288